Link to this page
PMO Precision Medicine Ontology
Last uploaded:
December 16, 2020
Jump to:
| Preferred Name | Idarubicin | |
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00016933 |
|
| Database_Cross_Reference |
NDFRT:N0000147874 VANDF:4019784 NDFRT:N0000007060 MTH:NOCODE NDDF:004819 MMSL:d00256 NCI_NCI-GLOSS:CDR0000044413 RCD:x01Ag NCI_FDA:ZRP63D75JW CHV:0000006530 DRUGBANK:DB01177 ATC:L01DB06 NCI:C562 MTHSPL:ZRP63D75JW SNOMEDCT_US:372539000 RXNORM:5650 MSH:D015255 NCI_NCI-GLOSS:CDR0000045254 PDQ:CDR0000039753 SNOMEDCT_US:108786002
|
|
| label |
Idarubicin
|
|
| MCID |
MC00006670
|
|
| PMOID |
PMO:00016933
|
|
| prefixIRI |
pmo:PMO_00016933
|
|
| prefLabel |
Idarubicin
|
|
| Synonym |
4DMDR (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside Idarubicin [Chemical/Ingredient] Idarubicin (substance) DEMETHOXYDAUNORUBICIN 04 Idamycin - Cap 5mg DMDR 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)- (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-hexopyranoside Idarubicin (product) 4-Demethoxydaunorubicin 4-Demethoxydaunomycin IDA 4-demethoxydaunorubicin (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione Idarubicina 4 Desmethoxydaunorubicin 4 Demethoxydaunorubicin Idamycin - Cap 25mg Idamycin Powder -5mg/vial idarubicin Idamycin Pws 10mg/vial Aj-idarubicin Idarubicinum Idamycin Pws 5mg/vial Idamycin - Cap 10mg Idarubicin Hydrochloride Injection IDARUBICIN 4-Desmethoxydaunorubicin Idamycin Powder -10mg/vial Idarubicine 4-DMDR IDArubicin
|
|
| Tree Number |
T6.10.1.2.2.3.3 T6.2.30.6.1.1.2.2.3.3 T6.4.13.7.4.4.8.9.11.3.3 T6.5.8.9.11.3.3
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping